BlackRock Advisors’s Biolase, Inc. BIOL Stock Holding History

BlackRock Advisors’s Portfolio BIOL Stock Details BIOL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$16K	Hold	1	–	–	﹤0.01%	3500
2016 Q3	$19K	Hold	1	–	–	﹤0.01%	3468
2016 Q2	$13K	Hold	1	–	–	﹤0.01%	3539
2016 Q1	$15K	Hold	1	–	–	﹤0.01%	3505
2015 Q4	$9K	Hold	1	–	–	﹤0.01%	3644
2015 Q3	$10K	Hold	1	–	–	﹤0.01%	3659
2015 Q2	$19K	Hold	1	–	–	﹤0.01%	3525
2015 Q1	$22K	Hold	1	–	–	﹤0.01%	3432
2014 Q4	$29K	Hold	1	–	–	﹤0.01%	3410
2014 Q3	$28K	Hold	1	–	–	﹤0.01%	3420
2014 Q2	$24K	Sell	1 -1	-50%	-$25.5K	﹤0.01%	3409
2014 Q1	$67K	Hold	2	–	–	﹤0.01%	3181
2013 Q4	$73K	Hold	2	–	–	﹤0.01%	3158
2013 Q3	$43K	Hold	2	–	–	﹤0.01%	3219
2013 Q2	$68K	Buy	+2	New	+$112K	﹤0.01%	3086

Other funds holding BIOL

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return

GIP

Granite Investment Partners El Segundo, California $1.63B AUM 38.09% 1-Year Est. Return

Teton Advisors Rye, New York $142M AUM 42.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock Advisors's BIOL Position: Q4 2016 in Review

BlackRock Advisors held its Biolase, Inc. (BIOL) position steady in Q4 2016 at 1 share worth $16K. The position accounts for ﹤0.01% of the portfolio, ranked #3500.

BlackRock Advisors first reported a position in BIOL in Q2 2013 and has held it in 15 quarters since. The position peaked at $73K in Q4 2013. 34 funds tracked by Wall St. Rank hold BIOL as of Q4 2016.

BlackRock Advisors held 1 share of Biolase, Inc. worth $16K as of Q4 2016.
BlackRock Advisors left its Biolase, Inc. share count unchanged in Q4 2016.
Biolase, Inc. made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #3500 holding.
BlackRock Advisors first reported a position in Biolase, Inc. in Q2 2013 and has held it in 15 quarters since.
BlackRock Advisors's Biolase, Inc. position peaked at $73K in Q4 2013.
34 funds tracked by Wall St. Rank held Biolase, Inc. as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.